Clinical Trials Browser

Phase 3 × Neoplasms × Carboplatin × Clear all

NCT05256225 2026-05-27

Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma

Phase 3 Recruiting

360 enrolled

Gynecologic

Neoplasms, Endometrial Neoplasms

NCT06119581 2026-05-19

SUNRAY-01

Phase 3 Recruiting

1,264 enrolled

Thoracic

Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, Lung Diseases, Lung Neoplasms, Neoplasm Metastasis, Neoplasms, Neoplasms by Site, Neoplastic Processes, Pathologic Processes, Respiratory Tract Diseases, Respiratory Tract Neoplasms, Thoracic Neoplasms

NCT04222972 2026-03-05

AcceleRET-Lung

Phase 3 Terminated

223 enrolled 18 charts

Head & NeckThoracic

Adenocarcinoma, Bronchial Diseases, Carcinoma, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Lung Diseases, Lung Neoplasms, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Respiratory Tract Diseases, Respiratory Tract Neoplasms, Thoracic Neoplasms

NCT05223647 2026-01-28

TRIPLEX

Phase 3 Terminated

239 enrolled

Thoracic

Neoplasms, Small Cell Lung Carcinoma

NCT03981796 2025-09-03

RUBY

Phase 3 Active not recruiting

785 enrolled 2 FDA

Neoplasms, Recurrence

NCT03603184 2025-05-09

AtTEnd

Phase 3 Completed

549 enrolled

Gynecologic

Neoplasms, Endometrial Neoplasms

NCT00446225 2025-03-05

EURTAC

Phase 3 Completed

174 enrolled 20 charts

Thoracic

Carcinoma, Non-Small-Cell Lung, Neoplasms

NCT05384366 2022-05-20

Neoadjuvant Chemotherapy in Cervical Cancer

Phase 3 Completed

33 enrolled

Gynecologic

Uterine Cervical Neoplasms, Neoplasms

NCT02810457 2022-03-10

AVANA

Phase 3 Completed

731 enrolled 19 charts

Thoracic

Carcinoma, Non-Small-Cell Lung, Neoplasms

NCT02032277 2021-01-20

A Study Evaluating Safety and Efficacy of the Addition of ABT-888 Plus Carboplatin Versus the Addition of Carboplatin to Standard Chemotherapy Versus Standard Chemotherapy in Subjects With Early Stage Triple Negative Breast Cancer

Phase 3 Completed

634 enrolled

Breast

Neoplasms, Triple Negative Breast Neoplasms

NCT03402048 2020-11-04

EPIC

Phase 3 Unknown

567 enrolled

Thoracic

Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, Lung Diseases, Lung Neoplasms, Neoplasms, Respiratory Tract Diseases, Respiratory Tract Neoplasms, Thoracic Neoplasms

NCT00460317 2015-09-07

MONET1-MOtesanib NSCLC Efficacy and Tolerability Study

Phase 3 Terminated

1,450 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Neoplasms